Page last updated: 2024-10-29

indomethacin and Dysgammaglobulinemia

indomethacin has been researched along with Dysgammaglobulinemia in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Dysgammaglobulinemia: An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tikjonova, LV1
Mukhamedieva, SM1
Sattarov, GN1

Other Studies

1 other study available for indomethacin and Dysgammaglobulinemia

ArticleYear
[Clinico-immunologic characteristics of Salmonella infection in children during pathogenetic therapy].
    Pediatriia, 1989, Issue:4

    Topics: Child, Preschool; Dysgammaglobulinemia; Humans; IgA Deficiency; IgG Deficiency; Indomethacin; Infant

1989